GlassScriptPhysician profile
Ho Young Cho
NPI 1245355080
$4,133.17
in general payments reported to CMS, 2019-2025
14 companies · $893 in 2025
The $893 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $67.93 · 2021: $299 · 2022: $266 · 2023: $339 · 2024: $727 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804 · Entertainment: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,804.24 |
| Entertainment | $154.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,690.96 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Alcon Vision LLC | $616.51 | 2021-2025 | Precision 1, Total30, Dailies Total1 |
| Optos, INC. | $339.17 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $303.63 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $259.61 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $250.00 | 2023-2025 | Infuse |
| Sight Sciences, INC. | $171.71 | 2022-2023 | Tearcare System |
| Abbvie INC. | $121.54 | 2024 | |
| Genzyme Corporation | $113.38 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $80.00 | 2022 | |
| Lombart Brothers, INC. | $60.38 | 2025 | Opd-III |
| Lkc Technologies, INC. | $58.40 | 2024 | |
| Visionix USA, INC | $38.47 | 2024 | Optical Coherence Tomography Hoct-1f |
| Optovue, INC. | $29.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ho Young Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.